AnalystBro Research
Research
Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.
3 articles.
Bangladesh All Bangladesh research →
Company · DSE:SAMORITA · Pharma & healthcare · Analysis · 01 Nov 2026
Samorita Hospital: revenue BDT 401.4m in FY2025, land BDT 884.3m on the balance sheet, FY2026 EPS BDT 1.12
Revenue reached BDT 401.4m in FY2025 and the DSE-announced FY2026 EPS rose to BDT 1.12 from 0.62; net margin has stayed between 0.2% and 4.8% since FY2022, the auditor qualified the FY2025 accounts on WPPF and gratuity, and the stock trades at 74x FY2026 EPS and 1.71x NAV.
Company · DSE:SONALIANSH · Jute · Analysis · 31 Oct 2026
Sonali Aansh Industries: FY2025 sales of BDT 1.73bn, export subsidy of BDT 86m against profit before tax of BDT 126m, and a fifth straight qualified audit
The jute-yarn exporter's sales rose 119% in FY2025 and EPS was BDT 8.79; the subsidy line equalled 69% of profit before tax, the FY2025 auditor's basis for qualified opinion lists ten items, and FY2026 EPS of BDT 8.87 was announced on 01-Nov-2026.
Company · DSE:BESTHLDNG · Hotels, ports, shipping & real estate · Analysis · 29 Oct 2026
Best Holdings: Le Méridien earnings fell 77% in FY2025 as BDT 18bn of debt and bond interest hit the P&L
Revenue fell 29% to BDT 2.43bn after the July-August 2024 unrest, finance cost rose six-fold to BDT 493m, EPS was BDT 0.30 and no dividend was declared; BDT 18.7bn of hotel projects are still under construction.